Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AC5 Topical Gel

K-Number: K182681 · 2018-12-14

ApplicantArch Therapeutics, Inc.
Decision Date2018-12-14
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

AC5 Topical Gel is the device name listed in this FDA 510(k) record. The listed applicant is Arch Therapeutics, Inc.. It received FDA 510(k) clearance on 2018-12-14 under 510(k) number K182681. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AC5 Topical Gel?

AC5 Topical Gel is a medical device that received FDA 510(k) clearance on 2018-12-14. The listed applicant is Arch Therapeutics, Inc.. The 510(k) number is K182681.

When did AC5 Topical Gel receive FDA 510(k) clearance?

AC5 Topical Gel received FDA 510(k) clearance on 2018-12-14, under 510(k) number K182681.

Who is the listed applicant for AC5 Topical Gel?

The FDA 510(k) record lists Arch Therapeutics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AC5 Topical Gel?

The FDA product code for AC5 Topical Gel is FRO. This falls under the Anesthesiology category.

Other records listing Arch Therapeutics, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K190129AC5 Topical Gel

Related Devices (Code: FRO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261646Redermax® Antibacterial Wound MatrixBeijing Kreate Medical Co., Ltd.K253665Vashe Plus Antimicrobial SolutionUrgo Medical North America, LLCK261023Microdacyn Wound Irrigation SolutionSonoma Pharmaceuticals, Inc.K251929SilverCeuticals® Antimicrobial Wound GelSilverceuticals, Inc.K261638Bonvadis®Oneness Biotech Co., Ltd.K254073StatSeal DiscMerit Medical Systems, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑